Degenerative Cervical Disc Disease Clinical Trial
Official title:
PRESTIGE Observational Study
Prestige artificial disc replacement is an alternative treatment option with 16 years of
experience addressing the unmet needs of surgical fusion interventions. Previous studies on
the PRESTIGE® cervical disc have proven the safety and effectiveness of artificial disc
surgery with level I evidence.
The PRESTIGE Observational Study is intended to collect prospectively observational data
primarily on the Quality of Life (QoL).
Degenerative cervical disc disease is associated with a very high burden to the patient and
the society. If conservative treatment options fail, surgical interventions are the last
treatment option.
Symptomatic disc degeneration leads to neck pain, which can radiate to the scapula and arm,
with dumbness and tingling, and sometimes grasping and walking difficulties. At an advanced
stage, muscle weakness can be observed in the nerve territory.
The quality of life and functionality of patients with therapy-resistant (conservatively
treated) severe degeneration of the disc is greatly impaired, as they suffer from intense
pain and thus disability. Patients of working age were significantly more impacted by their
symptoms than older patients. They are no longer able to fully participate in everyday
activities.
Cervical neck pain resulting from degenerative disc disease is associated with a major
economic burden for payers.
Traditional cervical surgical decompressions and fusions are currently the most common
treatment option. Despite good treatment success rates, fusions are associated with a
negative impact on the normal kinematics of the spine, long recuperation times and long
absence from work. Prestige artificial disc replacement is an alternative treatment option.
The PRESTIGE Observational Study is intended to collect information on Quality of Life (QoL)
prior and after PRESTIGE® Cervical Disc surgery; data on pain prior of participation to the
study, drug regiment and X-ray evaluation throughout the course of the study will be
obtained. In addition adverse events and economic data will be documented.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01491399 -
INFUSE™ BONE GRAFT/CORNERSTONE-SR™ Allograft Ring/ATLANTIS™ Anterior Cervical Plate- Pilot Study
|
N/A | |
Completed |
NCT00642876 -
PRESTIGE® Cervical Disc Study
|
N/A | |
Terminated |
NCT01491477 -
INFUSE ® Bone Graft/CORNERSTONE-SR® Allograft Ring/ATLANTIS® Anterior Cervical Plate System Pivotal Trial
|
N/A |